Multiple osteochondromas (MO) is an inherited skeletal disorder, and the molecular mechanism of MO remains elusive. Exome sequencing has high chromosomal coverage and accuracy, and has recently been successfully used to identify pathogenic gene mutations. In this study, exome sequencing followed by Sanger sequencing validation was first used to screen gene mutations in two representative MO patients from a Chinese family. After filtering the data from the 1000 Genome Project and the dbSNP database (build 132), the detected candidate gene mutations were further validated via Sanger sequencing of four other members of the same MO family and 200 unrelated healthy subjects. Immunohisto-chemisty and multiple sequence alignment were performed to ...
Hereditary multiple exostoses (HME), the most frequent of all skeletal dysplasias, is an autosomal d...
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder characterized...
We describe the results of an optimised DHPLC-based mutation screening of the EXT1 and EXT2 genes in...
International audienceMultiple osteochondromas (MO), the most common type of benign bone tumor, is a...
Multiple osteochondromas (also called hereditary multiple exostoses) is an autosomal dominant disord...
Item does not contain fulltextMutations in either the EXT1 or EXT2 genes lead to Multiple Osteochond...
We describe here the spectrum and distribution of mutations in the EXT1 and EXT2 genes in the larges...
Hereditary multiple osteochondromas (HMO) is a rare autosomal dominant skeletal disorder, caused by ...
Multiple osteochondromatosis, also known as hereditary multiple exostoses (HME), is an inherited aut...
Hereditary multiple osteochondromas (HMO) is a rare autosomal dominant skeletal disorder, caused by ...
SummaryHereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder charac...
<div><p>Genetic disorders of the skeleton comprise a large group of more than 450 clinically distinc...
SummaryHereditary multiple exostoses (HME), the most frequent of all skeletal dysplasias, is an auto...
Multiple osteochondromas (MO) is an autosomal-dominant skeletal disorder caused by mutations in the ...
SummaryOsteochondromas occur as sporadic solitary lesions or as multiple lesions, characterizing the...
Hereditary multiple exostoses (HME), the most frequent of all skeletal dysplasias, is an autosomal d...
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder characterized...
We describe the results of an optimised DHPLC-based mutation screening of the EXT1 and EXT2 genes in...
International audienceMultiple osteochondromas (MO), the most common type of benign bone tumor, is a...
Multiple osteochondromas (also called hereditary multiple exostoses) is an autosomal dominant disord...
Item does not contain fulltextMutations in either the EXT1 or EXT2 genes lead to Multiple Osteochond...
We describe here the spectrum and distribution of mutations in the EXT1 and EXT2 genes in the larges...
Hereditary multiple osteochondromas (HMO) is a rare autosomal dominant skeletal disorder, caused by ...
Multiple osteochondromatosis, also known as hereditary multiple exostoses (HME), is an inherited aut...
Hereditary multiple osteochondromas (HMO) is a rare autosomal dominant skeletal disorder, caused by ...
SummaryHereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder charac...
<div><p>Genetic disorders of the skeleton comprise a large group of more than 450 clinically distinc...
SummaryHereditary multiple exostoses (HME), the most frequent of all skeletal dysplasias, is an auto...
Multiple osteochondromas (MO) is an autosomal-dominant skeletal disorder caused by mutations in the ...
SummaryOsteochondromas occur as sporadic solitary lesions or as multiple lesions, characterizing the...
Hereditary multiple exostoses (HME), the most frequent of all skeletal dysplasias, is an autosomal d...
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder characterized...
We describe the results of an optimised DHPLC-based mutation screening of the EXT1 and EXT2 genes in...